TRACE
This multicentre, randomised, double-blind, placebo controlled trial enrolled 1749 patients with:
- acute MI
- wall motion index of 1.2 or below i.e. with significant left ventricular dysfunction and a high risk of death
Trandolapril therapy was commenced 3-7 days after MI and continued indefinitely.
Mortality was 22% lower in the Trandolapril arms when compared to the placebo arm.
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.